Decreased exposure of simvastatin and simvastatin acid in a rat model of type 2 diabetes. - sprookjes - yvandenbroek - TriplyDB

Decreased exposure of simvastatin and simvastatin acid in a rat model of type 2 diabetes.

Decreased exposure of simvastatin and simvastatin acid in a rat model of type 2 diabetes.

http://www.wikidata.org/entity/Q34138321

about

The enhanced atorvastatin hepatotoxicity in diabetic rats was partly attributed to the upregulated hepatic Cyp3a and SLCO1B1.Altered Expression of Transporters, its Potential Mechanisms and Influences in the Liver of Rodent Models Associated with Diabetes Mellitus and Obesity.Inhibition of insulin resistance by PGE1 via autophagy-dependent FGF21 pathway in diabetic nephropathy.Biocompatibility and osteogenesis of calcium phosphate composite scaffolds containing simvastatin-loaded PLGA microspheres for bone tissue engineering.Decreased exposure of atorvastatin in diabetic rats partly due to induction of hepatic Cyp3a and Oatp2.

P2860

Q37254214-92F17F5A-9EFA-468F-8D19-8BB6ACB07D90 Q38644392-946D3390-BF01-445A-A75C-A5ABA3B4BD0A Q47222519-DB9939A3-80C2-42A7-B4D8-E708AE0ADBF0 Q50449427-A8FDF706-CD15-434A-8D3C-E7EB50001783 Q53180947-9267CBC7-55CA-4745-83B3-7E9C6644EF83

P2860

Decreased exposure of simvastatin and simvastatin acid in a rat model of type 2 diabetes.

http://www.wikidata.org/entity/Q34138321

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Decreased exposure of simvastatin and simvastatin acid in a rat model of type 2 diabetes.

@ast

Decreased exposure of simvastatin and simvastatin acid in a rat model of type 2 diabetes.

@en

Decreased exposure of simvastatin and simvastatin acid in a rat model of type 2 diabetes.

@nl

type

label

Decreased exposure of simvastatin and simvastatin acid in a rat model of type 2 diabetes.

@ast

Decreased exposure of simvastatin and simvastatin acid in a rat model of type 2 diabetes.

@en

Decreased exposure of simvastatin and simvastatin acid in a rat model of type 2 diabetes.

@nl

prefLabel

Decreased exposure of simvastatin and simvastatin acid in a rat model of type 2 diabetes.

@ast

Decreased exposure of simvastatin and simvastatin acid in a rat model of type 2 diabetes.

@en

Decreased exposure of simvastatin and simvastatin acid in a rat model of type 2 diabetes.

@nl

P1433

Q34138321-CB0414B9-5D23-45B8-A159-6097CCE4B06F

P1476

Q34138321-41E449BE-F8C9-43FA-BDAF-B50C8ACFD31B

P2093

Q34138321-23A0829E-495D-4FFB-A4D0-35297F40D45D

Q34138321-24243E2E-AC8F-44B1-A7A0-FC9A0E79279A

Q34138321-3CA85D10-1065-41C1-8F57-F8AA86C87D50

Q34138321-5384B3F6-9FCE-43A2-8076-E7ADE566105A

Q34138321-5D5A5C5F-22F6-4301-89C6-A16F8BB8D111

Q34138321-654B8C19-C36A-4F2D-9C8A-C4659E3E02DE

Q34138321-79E240DB-32A7-4547-991F-5539E213665C

Q34138321-9E0F1EC6-9F18-48EB-B81F-11D6C2833BC9

Q34138321-C7F14026-541E-4E29-B11A-6CBD39700259

Q34138321-D3C1745C-A90A-4A42-AFA5-CD9E8DD45D3E

P2860

Q34138321-09A3AC65-6FCC-490E-997C-7D6EF9E15441

Q34138321-0B2444B7-C6AB-4B67-ABE1-6D7045A822DE

Q34138321-0BAEE0BD-1B02-4CA0-B377-95B366D924E5

Q34138321-165FD901-D190-4729-8DA7-1AB3967BCB1C

Q34138321-18282294-640B-4703-B1F7-03A06FED1F95

Q34138321-1A0E89A2-0D80-4BE3-84AB-5E281878A227

Q34138321-23CF8F4D-7896-481F-B99F-DA26A7B8CD1F

Q34138321-244D1270-DA8A-456F-B16E-CBF49A0B78DC

Q34138321-25495BEC-2862-4349-A621-631D512B0E92

Q34138321-27D4630C-D791-49C0-B05B-1CD6E02A4454

P2888

Q34138321-7E6D04F8-E79F-4F84-8033-36AD07BB76DD

P304

Q34138321-03CDADD3-D4CB-4773-8D01-9E3FBBE41715

P31

Q34138321-2CC2C108-0433-4041-89C9-D1CA64251AE0

P356

Q34138321-09D787DA-FDD0-4445-A020-C9C740E8DF5D

P433

Q34138321-E28CAAA5-9986-44E4-BA7F-17B0DF043C61

P478

Q34138321-1D73294D-14C6-4B0B-A83E-8EB22E05A60F

P577

Q34138321-14B04E22-F4FD-4BB5-8F31-40482F307A29

P5875

Q34138321-4067C243-3244-493B-893A-772AB5D4138F

P6179

Q34138321-8FDEEEDF-6786-4CEE-B251-9BFC87CCD8E2

P698

Q34138321-EF218B9F-11CB-4D25-8808-1E807D3FEFD2

P921

Q34138321-8CB652E4-8D20-440D-93FA-369903897C39

P932

Q34138321-D593E60F-E4BB-42A3-A5B5-52DAAA0D83E1

P356

P1433

Acta Pharmacologica Sinica

P1476

Decreased exposure of simvastatin and simvastatin acid in a rat model of type 2 diabetes.

@en

P2093

Can Liu

http://www.w3.org/2001/XMLSchema#string

Da-wei Wang

http://www.w3.org/2001/XMLSchema#string

Dan Xu

http://www.w3.org/2001/XMLSchema#string

Feng Li

http://www.w3.org/2001/XMLSchema#string

Ji Zhang

http://www.w3.org/2001/XMLSchema#string

Jie Wu

http://www.w3.org/2001/XMLSchema#string

Li Liu

http://www.w3.org/2001/XMLSchema#string

Ling-ling Jia

http://www.w3.org/2001/XMLSchema#string

Meng-yue Hu

http://www.w3.org/2001/XMLSchema#string

Mian Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Clinical use and effectiveness of lipid lowering therapies in diabetes mellitus--an observational study from the Swedish National Diabetes Register

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis-Menten model.

The superfamily of organic anion transporting polypeptides.

The influence of simvastatin, atorvastatin and high-cholesterol diet on acetylcholinesterase activity, amyloid beta and cholesterol synthesis in rat brain.

Determination of Simvastatin in human plasma by liquid chromatography-mass spectrometry.

Two decades of progress in preventing vascular disease.

P2888

P304

1215-1225

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/APS.2014.39

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265018945

http://www.w3.org/2001/XMLSchema#string

P6179

1036918143

http://www.w3.org/2001/XMLSchema#string

P698

25152023

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

4155525

http://www.w3.org/2001/XMLSchema#string